BACKGROUND: The predictive significance of ST-segment elevation (STE) in lead V4 R in patients with anterior ST-segment elevation myocardial infarction (STEMI) has not been well-understood. In this study, we evaluated the prognostic value of early and late STE in lead V4 R in patients with anterior STEMI. METHODS: A total 451 patients with anterior STEMI who treated with primary percutaneous coronary intervention (PPCI) were prospectively enrolled in this study. All patients were classified according to presence of STE (>1 mm) in lead V4 R at admission and/or 60 min after PPCI. Based on this classification, all patients were divided into three subgroups as no V4 R STE (Group 1), early but not late V4 R STE (Group 2) and late V4 R STE (Group 3). RESULTS: In-hospital mortality had higher rates at group 2 and 3 and that had 2.1 and 4.1-times higher mortality than group 1. Late V4 R STE remained as an independent risk factor for cardiogenic shock (odds ratio [OR] 2.6; 95% confidence interval [CI] 1.9-4.3; p < .001) and in-hospital mortality (OR 2.3; 95% CI 1.8-4.1; p < .001). The 12-month overall survival for group 1, 2, and 3 were 91.1%, 82.4%, and 71.4% respectively. However, the long-term mortality also had the higher rate at group 3; late V4 R STE did not remain as an independent risk factor for long-term mortality (OR 1.5; 95% CI 0.8-4.1; p: .159). CONCLUSION: Late V4 R STE in patients with anterior STEMI is strongly associated with poor prognosis. The record of late V4 R in patients with anterior STEMI has an important prognostic value.
BACKGROUND: The predictive significance of ST-segment elevation (STE) in lead V4 R in patients with anterior ST-segment elevation myocardial infarction (STEMI) has not been well-understood. In this study, we evaluated the prognostic value of early and late STE in lead V4 R in patients with anterior STEMI. METHODS: A total 451 patients with anterior STEMI who treated with primary percutaneous coronary intervention (PPCI) were prospectively enrolled in this study. All patients were classified according to presence of STE (>1 mm) in lead V4 R at admission and/or 60 min after PPCI. Based on this classification, all patients were divided into three subgroups as no V4 R STE (Group 1), early but not late V4 R STE (Group 2) and late V4 R STE (Group 3). RESULTS: In-hospital mortality had higher rates at group 2 and 3 and that had 2.1 and 4.1-times higher mortality than group 1. Late V4 R STE remained as an independent risk factor for cardiogenic shock (odds ratio [OR] 2.6; 95% confidence interval [CI] 1.9-4.3; p < .001) and in-hospital mortality (OR 2.3; 95% CI 1.8-4.1; p < .001). The 12-month overall survival for group 1, 2, and 3 were 91.1%, 82.4%, and 71.4% respectively. However, the long-term mortality also had the higher rate at group 3; late V4 R STE did not remain as an independent risk factor for long-term mortality (OR 1.5; 95% CI 0.8-4.1; p: .159). CONCLUSION: Late V4 R STE in patients with anterior STEMI is strongly associated with poor prognosis. The record of late V4 R in patients with anterior STEMI has an important prognostic value.
Authors: Vicente Bodi; Juan Sanchis; Luis Mainar; Francisco J Chorro; Julio Nunez; Jose V Monmeneu; Fabian Chaustre; Maria J Forteza; Amparo Ruiz-Sauri; Maria P Lopez-Lereu; Cristina Gomez; Inmaculada Noguera; Ana Diaz; Francisco Giner; Angel Llacer Journal: Cardiovasc Res Date: 2010-03-19 Impact factor: 10.787
Authors: Eyyup Tusun; Mahmut Uluganyan; Murat Ugur; Gurkan Karaca; Faizel Osman; Bayram Koroglu; Ahmet Murat; Ahmet Ekmekci; Hüseyin Uyarel; Osman Sahin; Mehmet Eren; Osman Bolca Journal: Ann Noninvasive Electrocardiol Date: 2014-09-11 Impact factor: 1.468
Authors: S Charlap; N Schulhoff; S Mylavarapu; A Greengart; J Gelbfish; L Budzilowicz; G Hollander; E Lichstein; J Shani Journal: Am J Cardiol Date: 1989-09-15 Impact factor: 2.778
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Muhammed Keskin; Ahmet Okan Uzun; Edibe Betül Börklü; Mert İlker Hayıroğlu; Ceyhan Türkkan; Ahmet İlker Tekkeşin; Ömer Kozan Journal: Ann Noninvasive Electrocardiol Date: 2017-10-14 Impact factor: 1.468